Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3647394012 | Conventional release transdermal foam | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3647395013 | Conventional release transdermal foam (dose form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3647396014 | Transdermal foam | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Transdermal foam | Is a | Transdermal dose form | true | Inferred relationship | Some | ||
| Transdermal foam | Has dose form administration method | Apply | true | Inferred relationship | Some | ||
| Transdermal foam | Has dose form transformation | No transformation | true | Inferred relationship | Some | ||
| Transdermal foam | Has dose form intended site | Transdermal | true | Inferred relationship | Some | ||
| Transdermal foam | Has dose form release characteristic | Conventional release | true | Inferred relationship | Some | ||
| Transdermal foam | Has basic dose form | Foam | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Felbinac 31.7 mg/g transdermal foam | Has manufactured dose form | True | Transdermal foam | Inferred relationship | Some |
Reference Sets
Qualifier value foundation reference set
FHIR